LRRC17 anticorps (Middle Region)
Aperçu rapide pour LRRC17 anticorps (Middle Region) (ABIN632693)
Antigène
Voir toutes LRRC17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- LRRC17 antibody was raised against the middle region of LRRC17
-
Purification
- Affinity purified
-
Immunogène
- LRRC17 antibody was raised using the middle region of LRRC17 corresponding to a region with amino acids YVFPIQTLDCKRKELKKVPNNIPPDIVKLDLSYNKINQLRPKEFEDVHEL
-
-
-
-
Indications d'application
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
LRRC17 Blocking Peptide, (ABIN936254), is also available for use as a blocking control in assays to test for specificity of this LRRC17 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LRRC17 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LRRC17 (Leucine Rich Repeat Containing 17 (LRRC17))
-
Autre désignation
- LRRC17
-
Sujet
- LRRC17 contains 6 LRR (leucine-rich) repeats. The exact function of LRRC17 remains unknown.
-
Poids moléculaire
- 52 kDa (MW of target protein)
Antigène
-